BTIG analyst Justin Zelin has reiterated their bullish stance on MRSN stock, giving a Buy rating yesterday.Stay Ahead of the Market:Discover ...
As per the filing, Biogen has a 10.2% stake in Sage Therapeutics. The offer price, representing a 30% premium to the stock's ...
Jefferies analyst Dennis Ding maintained a Hold rating on Crinetics Pharmaceuticals (CRNX – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback